AZTR
Price
$0.26
Change
-$0.03 (-10.34%)
Updated
Jun 13 closing price
Capitalization
4.55M
65 days until earnings call
SAGE
Price
$6.70
Change
+$0.10 (+1.52%)
Updated
Jun 13 closing price
Capitalization
419.56M
52 days until earnings call
Interact to see
Advertisement

AZTR vs SAGE

Header iconAZTR vs SAGE Comparison
Open Charts AZTR vs SAGEBanner chart's image
Azitra
Price$0.26
Change-$0.03 (-10.34%)
Volume$542.24K
Capitalization4.55M
Sage Therapeutics
Price$6.70
Change+$0.10 (+1.52%)
Volume$647.39K
Capitalization419.56M
AZTR vs SAGE Comparison Chart
Loading...
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTR vs. SAGE commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTR is a Hold and SAGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (AZTR: $0.26 vs. SAGE: $6.70)
Brand notoriety: AZTR and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AZTR: 29% vs. SAGE: 77%
Market capitalization -- AZTR: $4.55M vs. SAGE: $419.56M
AZTR [@Biotechnology] is valued at $4.55M. SAGE’s [@Biotechnology] market capitalization is $419.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTR’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 1 green FA rating(s).

  • AZTR’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, SAGE is a better buy in the long-term than AZTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTR’s TA Score shows that 3 TA indicator(s) are bullish while SAGE’s TA Score has 4 bullish TA indicator(s).

  • AZTR’s TA Score: 3 bullish, 5 bearish.
  • SAGE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SAGE is a better buy in the short-term than AZTR.

Price Growth

AZTR (@Biotechnology) experienced а -4.03% price change this week, while SAGE (@Biotechnology) price change was -2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

AZTR is expected to report earnings on Aug 18, 2025.

SAGE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAGE($420M) has a higher market cap than AZTR($4.55M). SAGE YTD gains are higher at: 23.389 vs. AZTR (-37.955). AZTR has higher annual earnings (EBITDA): -8.5M vs. SAGE (-358.98M). SAGE has more cash in the bank: 424M vs. AZTR (4.56M). AZTR has less debt than SAGE: AZTR (556K) vs SAGE (11.9M). SAGE has higher revenues than AZTR: SAGE (47.4M) vs AZTR (7.5K).
AZTRSAGEAZTR / SAGE
Capitalization4.55M420M1%
EBITDA-8.5M-358.98M2%
Gain YTD-37.95523.389-162%
P/E Ratio0.00N/A-
Revenue7.5K47.4M0%
Total Cash4.56M424M1%
Total Debt556K11.9M5%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTRSAGE
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMCSX42.510.04
+0.10%
Fidelity Mid-Cap Stock
JFESX39.25N/A
N/A
JPMorgan Europe Dynamic I
TPICX13.96N/A
N/A
Timothy Plan International C
GTSDX8.59N/A
N/A
Invesco Small Cap Growth C
WSMGX19.73N/A
N/A
Wilshire Small Company Growth Instl

AZTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTR has been closely correlated with DARE. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if AZTR jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTR
1D Price
Change %
AZTR100%
-7.53%
DARE - AZTR
73%
Closely correlated
-2.88%
SLRX - AZTR
40%
Loosely correlated
-7.03%
SAGE - AZTR
35%
Loosely correlated
+1.52%
SNTI - AZTR
31%
Poorly correlated
-9.09%
MMIRF - AZTR
24%
Poorly correlated
N/A
More